SCHEMBL27384451

SCHEMBL27384451

CC(C)c1cc2[nH]c(CNC(=O)N3CCCC3C)cc2cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AADAT Q8N5Z0 3/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ HPGD P15428 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ TACR1 P25103 2/20 0.34
▸ SSTR3 P32745 1/20 0.34
▸ F10 P00742 1/20 0.34
▸ SLC2A1 P11166 1/20 0.34
▸ MTNR1A P48039 2/20 0.33
▸ MTNR1B P49286 2/20 0.33
▸ PDE9A O76083 1/20 0.33
▸ PDE1B Q01064 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384456 0.90 RAB9A (0.37) AADATRAB9ASMN1; SMN2POLBHRH3
SCHEMBL27384854 0.83 MAPK1 (0.41) RAB9AALDH1A1SMN1; SMN2POLBHRH3
SCHEMBL27384346 0.82 EIF4A3 (0.45) AADATRAB9AHPGDALDH1A1SMN1; SMN2
SCHEMBL27383269 0.79 RAB9A (0.56) RAB9AHPGDALDH1A1SMN1; SMN2POLB
SCHEMBL27384455 0.79 RAB9A (0.41) RAB9AHPGDALDH1A1SMN1; SMN2POLB
SCHEMBL27385164 0.78 RAB9A (0.41) RAB9ASMN1; SMN2MTNR1AMTNR1B
SCHEMBL27384349 0.78 SMN1; SMN2 (0.38) RAB9ASMN1; SMN2HRH3MAPK1
SCHEMBL27385039 0.78 RAB9A (0.42) RAB9AHPGDALDH1A1SMN1; SMN2MTNR1A
SCHEMBL27384178 0.77 SMN1; SMN2 (0.42) RAB9AHPGDSMN1; SMN2POLBSSTR3
SCHEMBL27385399 0.77 PKM (0.47) RAB9AHPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback